Terms: = Lung cancer AND MEN1, ENSG00000133895, 4221 AND Diagnosis
32 results:
1. Cutaneous lesions and other non-endocrine manifestations of Multiple Endocrine Neoplasia type 1 syndrome.
Pierotti L; Pardi E; Dinoi E; Piaggi P; Borsari S; Della Valentina S; Sardella C; Michelucci A; Caligo MA; Bogazzi F; Marcocci C; Cetani F
Front Endocrinol (Lausanne); 2023; 14():1191040. PubMed ID: 37484956
[TBL] [Abstract] [Full Text] [Related]
2. Neuroendocrine tumors in a patient with multiple endocrine neoplasia type 1 syndrome: A case report and review of the literature.
Deng J; Liao X; Cao H
Medicine (Baltimore); 2023 Jul; 102(29):e34350. PubMed ID: 37478229
[TBL] [Abstract] [Full Text] [Related]
3. Adult Pancreatoblastoma: Report of 3 new Cases With Genetic Diversity and Autopsy Findings.
Machado I; López-Guerrero JA; Fernandez A; López R; García Casado Z; Ferrandez A; Llombart-Bosch A; Charville GW
Int J Surg Pathol; 2023 Aug; 31(5):896-906. PubMed ID: 36573045
[TBL] [Abstract] [Full Text] [Related]
4. Germline Pathogenic Variants Impact Clinicopathology of Advanced lung cancer.
Mukherjee S; Bandlamudi C; Hellmann MD; Kemel Y; Drill E; Rizvi H; Tkachuk K; Khurram A; Walsh MF; Zauderer MG; Mandelker D; Topka S; Zehir A; Srinivasan P; Esai Selvan M; Carlo MI; Cadoo KA; Latham A; Hamilton JG; Liu YL; Lipkin SM; Belhadj S; Bond GL; Gümüş ZH; Klein RJ; Ladanyi M; Solit DB; Robson ME; Jones DR; Kris MG; Vijai J; Stadler ZK; Amos CI; Taylor BS; Berger MF; Rudin CM; Offit K
Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1450-1459. PubMed ID: 35477182
[TBL] [Abstract] [Full Text] [Related]
5. Update on the clinical management of multiple endocrine neoplasia type 1.
Pieterman CRC; Valk GD
Clin Endocrinol (Oxf); 2022 Oct; 97(4):409-423. PubMed ID: 35319130
[TBL] [Abstract] [Full Text] [Related]
6. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
[TBL] [Abstract] [Full Text] [Related]
7. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.
Ito T; Masui T; Komoto I; Doi R; Osamura RY; Sakurai A; Ikeda M; Takano K; Igarashi H; Shimatsu A; Nakamura K; Nakamoto Y; Hijioka S; Morita K; Ishikawa Y; Ohike N; Kasajima A; Kushima R; Kojima M; Sasano H; Hirano S; Mizuno N; Aoki T; Aoki T; Ohtsuka T; Okumura T; Kimura Y; Kudo A; Konishi T; Matsumoto I; Kobayashi N; Fujimori N; Honma Y; Morizane C; Uchino S; Horiuchi K; Yamasaki M; Matsubayashi J; Sato Y; Sekiguchi M; Abe S; Okusaka T; Kida M; Kimura W; Tanaka M; Majima Y; Jensen RT; Hirata K; Imamura M; Uemoto S
J Gastroenterol; 2021 Nov; 56(11):1033-1044. PubMed ID: 34586495
[TBL] [Abstract] [Full Text] [Related]
8. Well-Differentiated Bronchopulmonary Neuroendocrine Tumors: More Than One Entity.
van den Broek MFM; Levy S; Buikhuisen WA; Dijke K; Hartemink KJ; van Leeuwaarde RS; Vriens MR; Tesselaar MET; Valk GD;
J Thorac Oncol; 2021 Nov; 16(11):1810-1820. PubMed ID: 34352379
[TBL] [Abstract] [Full Text] [Related]
9. Low risk for all-cause mortality among patients with lung neuroendocrine tumors co-diagnosed with pituitary adenomas.
Peltz-Sinvani N; Percik R; Uri I; Kfir SK; Tirosh A; Tirosh A
Endocrine; 2021 Sep; 73(3):745-751. PubMed ID: 33982234
[TBL] [Abstract] [Full Text] [Related]
10. Multiple endocrine neoplasia type 1 (MEN-1) and neuroendocrine neoplasms (NENs).
Effraimidis G; Knigge U; Rossing M; Oturai P; Rasmussen ÅK; Feldt-Rasmussen U
Semin Cancer Biol; 2022 Feb; 79():141-162. PubMed ID: 33905872
[TBL] [Abstract] [Full Text] [Related]
11. Multiple endocrine neoplasia type 1 with refractory hypoglycemia and lung and liver metastases: a case report.
Wang Y; Zhang H
J Int Med Res; 2021 Jan; 49(1):300060520961682. PubMed ID: 33435778
[TBL] [Abstract] [Full Text] [Related]
12. Incidental finding of MEN-1 syndrome during staging and follow-up of breast carcinoma.
Maria BC; Quadros AC; Alves N; Coutinho J
BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33370954
[TBL] [Abstract] [Full Text] [Related]
13. Risk of second primary malignancies among patients with carcinoid of the lung.
Buikhuisen WA; Steinbusch LC; Kodach LL; Tesselaar MET; Damhuis RAM
Lung Cancer; 2021 Jan; 151():5-7. PubMed ID: 33278670
[TBL] [Abstract] [Full Text] [Related]
14. Randomised phase II trial of CAPTEM or FOLFIRI as SEcond-line therapy in NEuroendocrine CArcinomas and exploratory analysis of predictive role of PET/CT imaging and biological markers (SENECA trial): a study protocol.
Bongiovanni A; Liverani C; Pusceddu S; Leo S; Di Meglio G; Tamberi S; Santini D; Gelsomino F; Pucci F; Berardi R; Lolli I; Bergamo F; Ricci S; Foca F; Severi S; Ibrahim T;
BMJ Open; 2020 Jul; 10(7):e034393. PubMed ID: 32690499
[TBL] [Abstract] [Full Text] [Related]
15. Integrative Genomic Characterization Identifies Molecular Subtypes of lung Carcinoids.
Laddha SV; da Silva EM; Robzyk K; Untch BR; Ke H; Rekhtman N; Poirier JT; Travis WD; Tang LH; Chan CS
Cancer Res; 2019 Sep; 79(17):4339-4347. PubMed ID: 31300474
[TBL] [Abstract] [Full Text] [Related]
16. Prostate cancer Incidence and Mortality in Relationship to Family History of Prostate cancer; Findings From The PLCO Trial.
Abdel-Rahman O
Clin Genitourin Cancer; 2019 Aug; 17(4):e837-e844. PubMed ID: 31213414
[TBL] [Abstract] [Full Text] [Related]
17. Acromegaly associated with GIST, non-small cell lung carcinoma, clear cell renal carcinoma, multiple myeloma, medulla oblongata tumour, adrenal adenoma, and follicular thyroid nodules.
Jawiarczyk-Przybyłowska A; Wojtczak B; Whitworth J; Sutkowski K; Bidlingmaier M; Korbonits M; Bolanowski M
Endokrynol Pol; 2019; 70(2):213-217. PubMed ID: 30742299
[TBL] [Abstract] [Full Text] [Related]
18. Examining the role of access to care: Racial/ethnic differences in receipt of resection for early-stage non-small cell lung cancer among integrated system members and non-members.
Check DK; Albers KB; Uppal KM; Suga JM; Adams AS; Habel LA; Quesenberry CP; Sakoda LC
Lung Cancer; 2018 Nov; 125():51-56. PubMed ID: 30429038
[TBL] [Abstract] [Full Text] [Related]
19. Histologically Proven Bronchial Neuroendocrine Tumors in men1: A GTE 51-Case Cohort Study.
Lecomte P; Binquet C; Le Bras M; Tabarin A; Cardot-Bauters C; Borson-Chazot F; Lombard-Bohas C; Baudin E; Delemer B; Klein M; Vergès B; Aparicio T; Cosson E; Beckers A; Caron P; Chabre O; Chanson P; Du Boullay H; Guilhem I; Niccoli P; Rohmer V; Guigay J; Vulpoi C; Scoazec JY; Goudet P
World J Surg; 2018 Jan; 42(1):143-152. PubMed ID: 28785839
[TBL] [Abstract] [Full Text] [Related]
20. Somatic and germline mutations in NETs: Implications for their diagnosis and management.
Minnetti M; Grossman A
Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):115-27. PubMed ID: 26971848
[TBL] [Abstract] [Full Text] [Related]
[Next]
